Dov Kadmon, MD, discusses the role of MRI in the diagnosis, staging, and surveillance of prostate cancer. He then reviews two high quality studies that evaluate the possibility of MRI guided biopsies as an alternative to standard ultrasound biopsies.Read More
Dov Kadmon, MD
Baylor College of Medicine
Dr. Kadmon received his MD from Hadassah Medical School, Jerusalem, Israel, completed residencies at Rokah Municipal Governmental Medical Center, Jerusalem, Israel, and Washington University School of Medicine, St. Louis, MO, and received a Fellowship in Urologic Oncology at Washington University Affiliate Hospitals, St. Louis, MO. At present, Dr. Kadmon is a Professor of Urology at Baylor College of Medicine, Houston, TX. He is also a devoted clinician. In his practice, Dr. Kadmon focuses on diagnosing and treating prostate cancer. He is particularly interested in using surgical techniques to treat prostate cancer. Towards that end, he has performed more than 1,000 open radical prostatectomies as well as more than 1,000 robotic-assisted laparoscopic radical prostatectomies. Dr. Kadmon is also an internationally respected writer and researcher. He has published over 150 papers in the field of urology, and has received grant money for his research from the National Cancer Institute on multiple occasions. He has also served as a consultant on prostate cancer for the National Cancer Institute. Dr. Kadmon’s research interests include gene therapy and immunotherapy for prostate cancer, biological therapy for prostate cancer, and methods for preventing prostate cancer.